Role of IGF2 in the Study of Development and Evolution of Prostate Cancer

• P. Porras-Quesada,
• JM. González-Cabezuelo,
• V. Sánchez-Conde,
• I. Puche-Sanz,
• V. Arenas-Rodríguez,
• C. García-López,
• JF. Flores-Martín,
• JM. Molina-Hernández,
• MJ. Álvarez-Cubero,
• MJ. Álvarez-Cubero,
• MJ. Álvarez-Cubero,
• LJ. Martínez-González,
• F. Vázquez-Alonso

Affiliations

P. Porras-Quesada

Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain

JM. González-Cabezuelo

Research and Development Department, Meridiem Seeds, Almería, Spain

V. Sánchez-Conde

Urology Department, University Hospital Virgen de las Nieves, Granada, Spain

I. Puche-Sanz

Urology Department, University Hospital Virgen de las Nieves, Granada, Spain

V. Arenas-Rodríguez

Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain

C. García-López

Pathological Anatomy Service, University Hospital Virgen de las Nieves, Granada, Spain

JF. Flores-Martín

Urology Department, University Hospital of Jaen, Jaen, Spain

JM. Molina-Hernández

Urology Department, University Hospital Torrecárdenas, Almería, Spain

MJ. Álvarez-Cubero

Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain

MJ. Álvarez-Cubero

Department of Biochemistry and Molecular Biology III, Faculty of Medicine, University of Granada, Granada, Spain

MJ. Álvarez-Cubero

Biosanitary Research Institute (ibs. GRANADA), University of Granada, Granada, Spain

LJ. Martínez-González

Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government (GENYO), Granada, Spain

F. Vázquez-Alonso

Urology Department, University Hospital Virgen de las Nieves, Granada, Spain